Cardiovascular risk profile in high risk primary care patients not treated with lipid-lowering treatment

被引：0
|
作者：
Dallongeville, J. [1 ]
Bruckert, E. [2 ]
Ferrieres, J. [3 ]
Delaage, P. H. [4 ]
Thomas-Delecourt, F. [4 ]
Bonnelye, G. [5 ]
Kownator, S.
机构：
[1] Inst Pasteur, INSERM, U744, F-59019 Lille, France
[2] Hosp Pitie Salpetriere, AP HP, Div Endocrinol & Metab, Paris, France
[3] Hop Rangueil, Univ Hosp Toulouse, Dept Cardiol B, Toulouse, France
[4] AstraZeneca France, Rueil Malmaison, France
[5] Kantar Hlth, Montrouge, France
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [1] CARDIOVASCULAR RISK PREVALENCE IN HIGH RISK PRIMARY CARE PATIENTS NOT TREATED WITH LIPID-LOWERING TREATMENT IN FRANCE, RESULTS OF AN ONLINE STUDY
    Kownator, S.
    Ferrieres, J.
    Bruckert, E.
    Bonnelye, G.
    Thomas-delecourt, F.
    Delaage, P. H.
    Dallongeville, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A345 - A345
  • [2] Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
    Lis, Anna
    Lis, Paulina
    Lowicka, Weronika
    Grabarczyk, Malgorzata
    Wita, Michal
    Zarczynski, Piotr
    Zarczynska, Malgorzata
    Haberka, Maciej
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
  • [3] Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital
    Spighi, Alessandro
    Tartagni, Elisa
    D'Addato, Sergio
    Dormi, Ada
    Borghi, Claudio
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (04) : 270 - 275
  • [4] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [5] Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Egede, Rasmus
    Jensen, Lisette Okkels
    Hansen, Henrik Steen
    Antonsen, Lisbeth
    Hansen, Knud Norregaard
    Junker, Anders
    Thayssen, Per
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) : 376 - 379
  • [6] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    [J]. DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [7] Cardiovascular risk factors and use of lipid-lowering therapy in a cohort of HIV-positive patients with high cardiovascular risk
    Denman, Johanna
    Manavi, Kaveh
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [8] Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease
    Knowles, Joshua W.
    Howard, William B.
    Karayan, Lala
    Baum, Seth J.
    Wilemon, Katherine A.
    Ballantyne, Christie M.
    Myers, Kelly D.
    [J]. CIRCULATION, 2017, 135 (22) : 2204 - 2206
  • [9] Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK
    Danese, Mark
    Sidelnikov, Eduard
    Villa, Guillermo
    Catterick, David
    Iqbal, Mazhar
    Gleeson, Michelle
    Lubeck, Deborah
    Patel, Jeetesh
    [J]. BMJ OPEN, 2022, 12 (04):
  • [10] New Treatment Targets and Innovative Lipid-Lowering Therapies in Very-High-Risk Patients with Cardiovascular Disease
    Burger, Achim Leo
    Pogran, Edita
    Muthspiel, Marie
    Kaufmann, Christoph Clemens
    Jaeger, Bernhard
    Huber, Kurt
    [J]. BIOMEDICINES, 2022, 10 (05)
12345